Table 4.

Mean MAP reduction per number of BP medications

Estimate95% CIP value
LowerHigher
Prior HTN     
2 BP medications −1.44 −4.72 1.84 .39 
3 BP medications −0.23 −4.70 4.23 .91 
≥4 BP medications −4.81 −9.93 0.30 .07 
de novo HTN     
1 BP medication −2.08 −5.65 1.49 .25 
2 BP medications −2.41 −6.43 1.61 .24 
≥3 BP medications −5.70 −9.94 −1.46 .008 
All patients combined     
1 BP medication −1.06 −4.50 2.38 .54 
2 BP medications −2.28 −5.93 1.36 .22 
3 BP medications −1.60 −6.11 2.90 .48 
≥4 BP medications −6.27 −11.8 −0.69 .02 
Estimate95% CIP value
LowerHigher
Prior HTN     
2 BP medications −1.44 −4.72 1.84 .39 
3 BP medications −0.23 −4.70 4.23 .91 
≥4 BP medications −4.81 −9.93 0.30 .07 
de novo HTN     
1 BP medication −2.08 −5.65 1.49 .25 
2 BP medications −2.41 −6.43 1.61 .24 
≥3 BP medications −5.70 −9.94 −1.46 .008 
All patients combined     
1 BP medication −1.06 −4.50 2.38 .54 
2 BP medications −2.28 −5.93 1.36 .22 
3 BP medications −1.60 −6.11 2.90 .48 
≥4 BP medications −6.27 −11.8 −0.69 .02 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal